DALLAS REGIONAL MEDICAL CENTER — History
CCN 450688 | 3-year financial timeline | COVID resilience: 45/100
🛡️ Public data only — no PHI permitted on this instance.
$107M
Latest Revenue (FY2022)
+3.6%
Revenue CAGR (3yr)
2.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $99M | $104M | $107M | +2.4% | +3.6% |
| Operating Expenses | $92M | $94M | $104M | +10.7% | +6.7% |
| Operating Margin | 7.8% | 9.5% | 2.2% | -77.3% | -47.3% |
| Net Income | $8M | $10M | $2M | -76.8% | -45.4% |
| Licensed Beds | 202 | 202 | 202 | +0.0% | +0.0% |
| Total Patient Days | 33,770 | 31,116 | 29,000 | -6.8% | -7.3% |
| Medicare Day % | 21% | 18% | 17% | -0.6% | -8.9% |
| Medicaid Day % | 4% | 7% | 3% | -62.2% | -21.2% |
COVID Impact & Recovery
Resilience Score: 45/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +7.3% ($99M → $107M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.6%
This Hospital
+7.6%
State Avg
Latest Margin
2.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $110M | -0.6% |
| FY2024 (proj) | $114M | -3.5% |
| FY2025 (proj) | $117M | -6.3% |